Sipa via AP Images

STAT+ | Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

UniQure will submit a marketing application in the third quarter seeking accelerated approval for the treatment, called AMT-130.

By Adam Feuerstein

NIH diversity programs doubled undergraduates’ odds of getting a Ph.D., 20-year study finds

Study in Science Advances finds two NIH diversity initiatives doubled odds of students getting a Ph.D. Trump administration ended both.

By Anil Oza

STAT+ | A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry

Canaan’s Julie Grant weighs in on a growing debate, the state of biotech broadly, and what flashy IPOs outside biotech mean for the sector.

By Allison DeAngelis

Adobe

Opinion: As a physician, I have never been more concerned about rates of congenital syphilis

Congenital syphilis is a sentinel event demonstrating failure of the local public health program.

By Jeffrey D. Klausner

FTC, four state AGs sue transgender health group over care standards

FTC and four state attorneys general allege gender-affirming group WPATH misled children and parents about the benefits, risks of surgeries and drugs.

By Theresa Gaffney and Bob Herman

Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing

Luigi Mangione to claim he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.

By Associated Press

Adobe

Opinion: The quiet joy of being an oncologist

Treating cancer patients is difficult. But it also brings special moments of joy and connection, an oncologist writes.

By Khushali Jhaveri

Opinion: How STAT decided to keep ‘health care’ as two words

On the "First Opinion Podcast," STAT’s director of editorial operations talks about keeping "health care" as two words.

By Torie Bosch